CTLA4 and cancer: The combination of sch rhIL-15 with both anti-CTLA4 and anti-PD-L1 was tested in the CT26 and MC38 colon carcinoma and in the Transgenic Adenocarcinoma Mouse Prostate C2 (TRAMP-C2) cancer models in mice.